NeuroBionics aims to advance neurotech and human health through bioelectronic medicine, by developing devices that seamlessly integrate with the human body.
Investors 1
Mentions in press and media 2
| Date | Title | Description |
| 09.12.2025 | DexMat, Inc. Secures Landmark Offtake Agreement with NeuroBionics for Galvorn® Carbon Nanotube Fiber, Advancing Minimally-Invasive Neuromodulation Platform | With DexMat Advancing Galvorn Toward Full Commercial Scale, NeuroBionics and Other Innovators Are Using the Breakthrough Material to Redefine Their Industries HOUSTON, Dec. 9, 2025 /PRNewswire-PRWeb/ -- DexMat, Inc., the leading provider of... |
| - | NeuroBionics | “NeuroBionics aims to advance neurotech and human health through bioelectronic medicine, by developing devices that seamlessly integrate with the human body.” |